RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q2 EPS of ($0.65), $0.56 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.